PRO362 polypeptides
The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer, and nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing such antigens PRO301, PRO362 or PRO245.
Genentech, Inc.
Y C C C C
Y02A C07K C07K C07K C07K
additional additional inventional additional inventional
Audrey Daniel Austin L. William I.
Goddard Tumas Gurney Wood